l4 C]acetate oxidation in isolated perfused rat hearts have been determined over a range of perfusion conditions. Effluent measurements demonstrated that I4 CO 2 cleared biexponentially over 50 minutes after bolus injection of [ll4 C]acetate into normoxic hearts perfused with 5 mM glucose and 10 mU/ml insulin. The clearance half-time (t r/2 ) for the predominant initial clearance phase was 3.1 ±0.5 minutes (n = 4). MVo 2 was varied over a fourfold range by hypoxia and phenylephrine stimulation (t w , 7.2 ± 1.2 and 2.2 ±0.2 minutes, respectively) and in the presence of alternate substrates (lactate, 2 mM; DL-3-hydroxybutyrate, 20 mM; and palmitate, 0.1 mM), which did not modify either tricarboxylic acid (TCA) cycle flux or acetate kinetics. A good correlation (r=0.93) was observed between k, the rate constant for the initial phase of Received April 7, 1987; accepted April 14, 1988. qualitatively myocardial oxidative metabolism, the rate constant for initial clearance of palmitate from myocardium being decreased in ischemia. '-4 Clearance of palmitate from reperfused or "stunned" myocardium was also slowed but returned to normal over time, correlating well with normalization of mechanical function.
qualitatively myocardial oxidative metabolism, the rate constant for initial clearance of palmitate from myocardium being decreased in ischemia. '-4 Clearance of palmitate from reperfused or "stunned" myocardium was also slowed but returned to normal over time, correlating well with normalization of mechanical function. 3 However, quantitative assessment of myocardial oxidative metabolism and function by measurement of [l-"C]palmitate kinetics is complicated by the sensitivity of long-chain fatty acid oxidation to changes in substrate supply. 16 -8 Since all major myocardial oxidative fuels, including fatty acids, glucose, lactate, pyruvate, ketone bodies, and some amino acids are oxidized via conversion to acetyl coenzyme A (CoA) and passage through the tricarboxylic acid (TCA) cycle, 9 a tracer of TCA cycle flux might allow a more readily quantifiable assessment of overall oxidative metabolism in myocardium. Acetate is readily oxidized via the TCA cycle, and in myocardium is not metabolized via any other major pathways. 10 -12 Initial studies in dogs 12 and human subjects 13 with [l-"C]acetate have demonstrated monoexponential clearance of "C activity from myocardial tissue. Clearance rates were slower in ischemic relative to normal tissue. This qualitative relation between oxidative metabolism and tissue clearance kinetics supported the potential usefulness of [l-"C]acetate for myocardial imaging and studies of myocardial oxidative metabolism. However, in the initial studies cited, no attempt was made to relate quantitatively acetate kinetics to TCA cycle flux. The present study was designed to investigate the relations between acetate oxidation, acetate kinetics, and TCA cycle flux in the isolated perfused rat heart, and to assess the effects of different myocardial substrates on acetate kinetics. The results support the potential of acetate for noninvasive assessment of myocardial oxidation by PET in vivo.
Materials and Methods
Langendorf perfusion of hearts from male SpragueDawley rats, 225-350 g, fed ad libitum was performed as described previously using a constant flow rate of 10 ml/min.
14 The pulmonary artery was cannulated for sampling cardiac effluent and for continuous monitoring of oxygen consumption using an on-line Clark-type oxygen electrode. The perfusate, Krebs-Henseleit bicarbonate buffer, 13 contained glucose, 5 mM, and insulin, 10 mU/ml; the calcium chloride concentration was 1.25 mM. For specific study protocols, additional substrates and hormones were administered by an infusion syringe into the perfusion line. Potassium chloride arrest was achieved by infusion of potassium chloride to give a perfusate concentration of 20 mM.
In washout experiments [l-M C]acetate (15 /iCi; specific activity, 10 mCi/mmol) was given as a bolus (0.3 ml) over 10 seconds. Effluent perfusate samples were collected for determination of I4 CO 2 and total 14 C activity. 14 CO 2 was determined by acidification of effluent perfusate samples in sealed 25-ml flasks and by trapping of 14 CO 2 with phenethylamine followed by liquid scintillation counting as described previously. 16 An aliquot of the acidified perfusate was scintillation-counted for determination of non- Results are expressed per gram dry weight; hearts were weighed after drying overnight at 150° C.
Results are given as mean±SD. Statistically significant differences were assessed by analysis of variance followed by Students t test with the Bonferroni method. A p<0.05 was considered statistically significant. Regression analysis was by weighted (1/y) least-squares.
Results
The time course of effluent perfusate I4 CO 2 and total I4 C activity following a bolus injection of [ll4 C]acetate into a representative rat heart perfused with glucose and insulin under control conditions is shown in Figure 1A . Peak Figure IB demonstrates the effect of hypoxia on myocardial acetate kinetics. Peak I4 CO 2 production occurred later, at 4.6 ±0.5 minutes (n = 4), and was followed by a clearance curve that, up to 50 minutes, could be fitted monoexponentially with a half-time of 7.2 ±1.2 minutes (n = 4; p<0.001 vs. control). However, in two experiments that were continued to 75 minutes, a second kinetic component was observed; due to the small amount of radioactivity in this component accurate quantitation was not possible, but t^ was approximately 20 minutes, similar to normoxia, although the relative size was greater, approximately 10% of the total. Since curve-stripping was not performed on hypox- ic hearts, comparisons of k in Table 1 and Figure 3 were made using unstripped monoexponential fits to the initial curve component. Values of it obtained for these monoexponential fits were 9.8 ±7.4% smaller than k obtained by biexponential fitting.
The fraction of total M C activity attributable to M CO 2 radioactivity in the effluent perfusate was decreased to 88% in hypoxia. However, t 1/2 for total 14 C clearance was not significantly different from I4 CO 2 clearance (Table 1) .
Phenylephrine, 10" (Table 1) .
In hearts using long-chain fatty acid and carbohydrate as energy sources, TCA cycle flux (in micromoles acetyl CoA units) can be estimated as one third of oxygen consumption (or two thirds in oxygen equivalents) since the non-TCA cycle oxygen consumption of these substrates is very similar. When acetate is present in nontracer amounts, acetate oxidation must be accounted for because 100% rather than 67% of the oxygen consumed by acetate is via the TCA cycle. Consequently, acetate (5 mM) stimulates TCA cycle flux in the perfused heart by 48-68%. 1116 The oxidation rate of acetate was therefore investigated as a function of acetate concentration ( Figure 2) . As the acetate concentration in the perfusate was increased from 36 /xm to 5 mM, acetate decarboxylation increased progres- (Table 1) . Acetate (0.5 mM and 5 mM) progressively decreased l in but at neither concentration was the difference from control significant. Acetate kinetics were also measured in KC1-arrested hearts, where a significant increase in t 1/2 to 6.0±0.3 minutes (n = 3) was observed (p<0.001).
TCA cycle fluxes were calculated from oxygen consumption rates and, when nontracer acetate concentrations were infused, steady-state acetate oxidation rates. Figure 3A shows the relation between TCA cycle flux and k, the rate constant for the initial component of I4 CO 2 clearance. TCA cycle flux and k correlated well (r=0.93) for experiments in which acetate was present only in tracer quantities (solid circles). However, although neither acetate concentration significantly decreased t|/2 (Table  1) , acetate (0.5 and 5 mM) caused a significant deviation from the relation between TCA cycle flux and M CO 2 clearance rates when acetate was present in the perfusate in only tracer amounts; the dashed line shows a weighted regression line for control experiments and acetate 0.5 and 5 mM. This line has a significantly different slope from that observed without nontracer acetate (p<0.01). Figure 3B represents the pooled estimates for all values obtained for TCA cycle flux and k. Lactate, palmitate, and DL-3-hydroxybutyrate were without significant effect on either TCA cycle flux or k, while as observed in Figure 3A , the addition of acetate in nontracer amounts caused divergence from the relation between TCA cycle flux and k.
To compare the sensitivity of acetate kinetics with alternate substrates in the perfusate with that of palmitate, washout experiments were performed with [l- tion from palmitate was significantly slower, t^ increasing to 4.3±0.2 minutes (n = 3; p<0.01; Figure 4B ). Oxygen consumption and hence TCA cycle flux were unchanged by lactate.
Discussion
In the presence of tracer acetate concentrations, a close correlation was observed between the rate of the initial rapid phase of M CO 2 clearance from myocardium and TCA cycle flux, as estimated from oxygen consumption. This finding supports the potential of labeled acetate for developing an in vivo radioassay method for determining regional TCA cycle flux. T l/2 for the initial M CO 2 clearance component, 3.1 ±0.5 minutes, is similar to that observed for clearance of U CO 2 from [2- C]pyruate (t m , 2.7 minutes), assumed to represent TCA cycle decarboxylation. 18 In the presence of 5 mM acetate, TCA cycle flux is stimulated by about 60%, partly due to increased oxygen consumption, but mainly due to the absence of reduced nicotinamide adenine dinucleotide generation by non-TCA cycle reactions when acetate serves as a substrate. 1117 It can be seen from Figure 3 that in the presence of acetate, k u the rate constant for the initial 14 CO 2 clearance component, was not increased proportionately with increased TCA cycle flux. Thus, in the presence of 5 mM exogenous acetate, k t underestimates TCA cycle flux by approximately 30% or about one half the stimulation of TCA cycle flux by acetate. Acetate infusion has been demonstrated to lead to a large increase in tissue acetyl CoA concentration in perfused hearts, 9 and it is possible that the underestimation of TCA cycle flux by k is related to the acetyl CoA pool size expansion. Since the cytosolic acetyl CoA pool has been proposed to act as an overflow when mitochondrial acetyl CoA is elevated, 19 the inclusion or expansion of an additional cytosolic acetyl CoA pool may account for the decrease in k.
Metabolism of acetate in myocardial tissue is less complex than that of long-chain fatty acids because 80-90% of acetate extracted by myocardium is oxidized.
1011 Activation of acetate in myocardial tissue by acetyl CoA synthase takes place primarily in the mitochondrial matrix, in contrast to liver and adipose tissue where the primarily cytoplasmic location of acetyl CoA synthase reflects extensive use of acetate for long-chain fatty acid biosynthesis.
2021
The inner mitochondrial membrane is impermeable to acetyl CoA, but acetyl CoA can be transferred to the cytosol via a carnitine-mediated acetyltransferase system. 2223 Williamson 10 demonstrated that in normoxic perfused hearts, less than 0.1% of acetate was incorporated into tissue lipid. Anoxia has been shown to increase esterification of M Cacetate 12-fold in perfused rat hearts 24 ; however, the extent of esterification was small, 1.3 ^mol • hr" glutamate representing the larger component.
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The second kinetic component for 14 C washout observed in the present study (t 1/2 approximately 17 minutes) may represent incorporation of the 14 C label into these amino acid pools and subsequent turnover, although this possibility has yet to be confirmed.
Plasma acetate levels are generally much lower than 5 mM. Normal levels reported in the literature for human plasma acetate concentration range from 30-250 /iM. 2627 Corresponding acetate oxidation rates in perfused rat heart are 0.5-3 /imol/g/min (Figure 2 ), which can be calculated to result in increases in TCA cycle flux of 2-10% compared with calculations based simply on MVo/J. Thus, under normal physiological conditions, underestimation of TCA cycle flux by k, due to acetate oxidation is likely to be insignificant. Since [1-"C]acetate can be synthesized at high specific activation (100-300 Ci/mmol), only -50 nmol of [1-"C]acetate need be injected for imaging purposes (-10 mCi). After ethanol administration however, blood acetate concentrations may reach 0.6-1 mM and remain elevated for several hours. 27 -28 PET measures only tissue concentrations of radiolabel rather than individual chemical species. The relation between clearance of labeled CO 2 and total radioactivity clearance is therefore of paramount importance if tissue clearance rates are to give accurate estimates of TCA cycle flux. It can be seen in Table 1 Central to the potential of acetate as an in vivo TCA cycle tracer is the demonstration that the alternate substrates of palmitate, lactate, and DL-3-hydroxybutyrate were without effect on k { . In control hearts to which [l-M C]palmitate was administered, k x was similar to that observed with [ll4 C]acetate, suggesting that under these conditions palmitate could be used as a TCA cycle tracer. However, inclusion of lactate (2 mM) caused a dissociation between k t for palmitate and TCA cycle flux. Although TCA cycle flux was unaltered, ki was significantly decreased, reflecting inhibition of long-chain fatty acid oxidation by lactate at a step prior to TCA cycle oxidation of acetyl CoA.
In conclusion, these results and the preliminary study of Brown et al 28 in perfused rabbit heart support the potential of [l-"C]acetate as a quantitative tracer of regional myocardial oxidative metabolism for use with PET. In addition, compared with [l-"C]palmitate, kinetics of [l-"C]acetate are relatively straightforward and insensitive to changes in myocardial substrate supply with the possible exceptions discussed above. This would allow the use of a rather simple tracer kinetic model to quantitate myocardial oxidative metabolism with [1-"C] acetate.
